Biogen Inc. buy hoffi69
Start price
01.11.12
/
50%
€106.94
Target price
01.02.13
€120.00
Performance (%)
6.61%
End price
01.02.13
€114.00
Summary
This prediction ended on 01.02.13 with a price of €114.00. With a performance of 6.61%, the BUY prediction by hoffi69 for Biogen Inc. closed with a slight gain. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -4.751% | -4.751% | 3.814% | -45.208% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
(Reuptake) Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt es sich nach dem Rücksetzer bei Biogen einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)